Seamless phase II-III adaptive trial design elements for progressive MS: Neurofilament light chain (phase II/interim endpoint), phase III endpoints and patient populations
Proceedings article published in 2019 by
D. R. Lieberman,
G. Giovannoni,
Fay Cafferty 
,
L. Bianchi,
S. Gnanapavan,
M. Marta,
D. R. Altmann,
R. Kapoor
,
L. Bianchi,
S. Gnanapavan,
M. Marta,
D. R. Altmann,
R. Kapoor
